2019 - 2021 Renal toxicities of small molecular agents
2016 - 2016 大規模副作用データベースを活用した腫瘍崩壊症候群の新規リスク分類の開発
Show all
Papers (25):
Akimasa Sanagawa, Tomoaki Hayakawa, Aya Yamamoto, Yuji Hotta, Yoko Furukawa-Hibi, Akimichi Morita. Effects of body mass index on hypertriglyceridemia associated with oral bexarotene therapy: a post-hoc analysis of an open-labeled comparative clinical study of combined bexarotene and phototherapy versus bexarotene monotherapy for Japanese patients with cutaneous T-cell lymphoma. Drugs in R&D. 2024. Accepted
Yuko Yamamoto, Masahiro Kondo, Yuji Hotta, Yuusuke Tashiro, Akimasa Sanagawa, Tomaya Kataoka, Yoko Furukawa-Hibi, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida, et al. The Relationship between Changes in Serum Element Concentrations and Pathological Condition and Disease Status in Japanese Multiple Myeloma Patients: A Pilot Study and Literature Review. Asian Pacific Journal of Cancer Prevention. 2023. 24. 7. 2493-2503
Akimasa Sanagawa, Tomoaki Hayakawa, Emi Nishida, Aya Yamamoto, Kyoko Ikumi, Yukari Mori, Yuji Hotta, Kazunori Kimura, Yoko Furukawa-Hibi, Akimichi Morita. Impact of body mass index on the severity of bexarotene-associated hypertriglyceridemia: A post hoc analysis of an open-labeled clinical study of combined bexarotene and phototherapy in Japanese patients with cutaneous T-cell lymphoma. The Journal of Dermatology. 2023. 50. 7. 917-926
Yuko Yamamoto, Yuji Hotta, Natsumi Tomita, Aya Naiki-Ito, Ayae Kitagawa, Urara Kuboshiki, Tamaki Hagita, Misuzu Noda, Akimasa Sanagawa, Tomoya Kataoka, et al. Changes in zinc and manganese concentrations in cisplatin-induced acute kidney injury. Biochemistry and biophysics reports. 2023. 33. 101422-101422
Natsumi Tomita, Yuji Hotta, Hidekazu Ito, Aya Naiki-Ito, Karin Matsuta, Yuko Yamamoto, Kazuki Ohashi, Tomoaki Hayakawa, Akimasa Sanagawa, Yasuhiro Horita, et al. High preoperative serum strontium levels increase the risk of acute kidney injury after cardiopulmonary bypass. Clinical and experimental nephrology. 2023
真川 明将. NO MORE HBV再活性化!. 日本薬学会第134年会 ハイライト要旨. 2014
Lectures and oral presentations (60):
Antifibrotic effects of tadalafil, a phosphodiesterase 5 inhibitor, with PAI1 downregulation via cGMP in rats and fibroblasts.
(American Society of Nephrology Kidney Week 2023 (Philadelphia, USA) 2023)